ATPC · XBRL financial data

Agape ATP financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (ATPC's year ends in late December)

In thousands of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Revenue3,4531,0171,8571,4311,3231,524
Revenue from contracts with customers3,4351,0171,8571,4311,3231,524
Cost of revenue——666495564686
Cost of goods and services sold776297666———
Gross profit2,6777201,191937759838
General and administrative1,6281,7461,9572,3663,1353,779
Total operating expenses2,8352,5782,7243,0833,3324,095
Operating income (loss)(158)(1,859)(1,533)(2,147)(2,573)(3,257)
Interest income—261629683
Other income (expense)164(43)(80)629114
Income tax expense (benefit)162137(4)452
Net income (loss)355(2,524)(1,687)(2,102)(2,470)(2,280)
Earnings per share, basic USD per share0.00(0.01)(0.02)(0.03)(0.63)(2.85)
Earnings per share, diluted USD per share——(0.02)(0.03)(0.63)(2.85)
Weighted average shares, basic thousands of shares376,388376,21687,82275,8153,892801
Weighted average shares, diluted thousands of shares——87,82275,8153,892801
  • † Share count changed about 1/5 in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/50 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (ATPC's year ends in late December)

In thousands of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Cash and cash equivalents3,5182,5981,4384,8322,040140
Marketable securities, non-current5778917201423
Accounts receivable173—3555412
Inventory59037646484627
Prepaid and other current assets29629619121658624,078
Total current assets5,6843,9122,0295,1852,77724,292
Property and equipment, net298216142783115
Right-of-use asset39423881357225102
Total assets7,2114,7252,7925,7443,24024,591
Total current liabilities1,0391,3131,2291,0721,1202,055
Total deposits1,1125555134,8172,030136
Lease liability, non-current24183—220759
Total liabilities1,2861,4121,2291,3641,3112,165
Accumulated deficit(734)(3,259)(4,946)(7,048)(9,518)(11,798)
Total stockholders' equity5,9253,3131,5424,3691,93322,460
Total liabilities and equity7,2114,7252,7925,7443,24024,591
Common shares outstanding (cover page) thousands of shares376,45275,45275,45276,96750,0051,001
  • † Share count changed about 1/5 in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/50 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (ATPC's year ends in late December)

In thousands of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024†Dec 31, 2025
Net income (loss)355(2,524)(1,687)(2,102)(2,470)(2,280)
Depreciation and amortization2—————
Net cash from operating activities(558)(846)(812)(2,002)(2,726)(2,413)
Purchases of property and equipment54————
Net cash from investing activities1,276(4)(32)(17)(50)(23,001)
Proceeds from issuing common stock———5,502—23,000
Net cash from financing activities(22)(19)(234)5,398(12)23,499
Net change in cash773(920)(1,159)3,394(2,792)(1,900)
  • † Share count changed about 1/5 in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/50 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Agape ATP45109(110)*1.0M0.4 quarters 10-QJun 30, 2026
Longduoduo1,589631*275*30.0M— 10-KJun 30, 2026
P3 Health Partners21,272386,381(61,914)*not reported0.3 quarters 10-QJun 30, 2026
Welsis00(11)2.8M— 10-QDec 31, 2025
Vsee Health4541,562(1,174)*56.7M0.4 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.